SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRentokil Initial Regulatory News (RTO)

Share Price Information for Rentokil Initial (RTO)

Share Price is delayed by 15 minutes
Get Live Data
453.60    3.80 (0.84%)
Bid:
452.90
Ask:
453.20
Spread: 0.30 (0.066%)
Market Cap: £11.41b
RTO Live PriceLast checked at - London Stock Exchange

Intraday Rentokil Initial Share Chart

Pension Scheme Deficit

19 Dec 2005 10:25

Rentokil Initial PLC19 December 2005 19 December 2005 RENTOKIL INITIAL plc ADDRESSES PENSION SCHEME DEFICIT In its third quarter update on 3 November 2005, Rentokil Initial plc ("theCompany") announced that it was in discussions with the Trustees of the DefinedBenefit (DB) Sections of the Rentokil Initial Pension Scheme ("the Scheme")regarding measures to address the Scheme's funding deficit and to ensureappropriate future funding levels. These discussions have resulted in thecompany proposing a series of positive steps which will deal with these issuesand protect the security of the Scheme's benefits for its members. The deficit of the UK Scheme under IAS 19 as at 30 November 2005 was estimatedto be £325 million. In response to a general trend of increasing longevity,which has adversely impacted the Scheme, the Company and Trustees have agreed toa more prudent basis for estimating longevity that will increase this deficit byan additional £24 million. An agreement has been reached between the Companyand the Trustees to make an immediate payment of £200 million, with theremaining deficit being met by a series of payments ending no later than January2012. The changed regulatory environment for pensions requires the Company todeal with these issues in a shorter timescale than it might otherwise have done.The total funding required to address the deficit will be in the range of £370million to £380 million depending on the final timing of the payments. In order to reduce the likelihood that the scheme deficit will increasematerially in the future, following discussions with the Company, the Trusteeswill be reviewing the Scheme's investment strategy, with the aim of reducingpotential volatility that might be caused by market movements. This will resultin a lower exposure to equities over time and improve the security of Schemebenefits. With immediate effect, the Company will be entering into a period ofcomprehensive consultation with active members of the DB Sections of the Scheme.The Company is proposing to close the DB Sections for the future accrual ofbenefits for active members. The aim of this is to reduce exposure to futureshortfalls and to ensure that the Scheme will be in a position to continue topay all benefits that have been earned to date by its members. It will alsoprovide the Company with more predictable costs of future pension provision.The proposed closure will have no impact on the scheme's deferred pensioners andpensions in payment. If the Company's proposals are implemented, existing active members of theScheme's DB Sections will be offered membership in a defined contributionarrangement so that they can continue to make provision for retirement. Final decisions regarding the review will be taken once the consultation periodwith active members has been completed later in 2006. Shareholder/analyst enquiriesAndrew Macfarlane, CFO Tel: 01342 833022Lisa Williams, Investor Relations Tel: 01342 833022 Media enquiriesCharles Grimaldi, Corporate Affairs Director Tel: 01342 833022Gill Ackers/Kate Miller, Brunswick Group LLP Tel: 020 7404 5959 Notes to editors: The Defined Benefit Sections of the Rentokil Initial Pension Scheme currentlyhas 3,000 active members, 15,000 deferred pensioners and 8,000 pensions inpayment. At 30 November 2005, the scheme had assets of £640 million and liabilities of£965 million. In the Lane Clark Peacock Accounting for Pensions Annual Survey 2005, RentokilInitial had the 96th lowest level of pension scheme funding out of the FTSE-100. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
25th Nov 20193:25 pmRNSHolding(s) in Company
14th Nov 20194:00 pmRNSHolding(s) in Company
8th Nov 20195:30 pmRNSHolding(s) in Company
8th Nov 20199:40 amRNSDirector/PDMR Shareholding
6th Nov 20195:00 pmRNSHolding(s) in Company
5th Nov 20195:10 pmRNSHolding(s) in Company
1st Nov 20197:00 amRNSAcquisition of Florida Pest Control, USA
31st Oct 20194:30 pmRNSDirector/PDMR Shareholding
17th Oct 20197:00 amRNS3rd Quarter Trading Update
30th Sep 201910:20 amRNSBlock listing Interim Review
23rd Sep 201910:30 amRNSHolding(s) in Company
13th Sep 20194:00 pmRNSDirector/PDMR Shareholding
19th Aug 20193:15 pmRNSDirector/PDMR Shareholding
5th Aug 20191:58 pmRNSDirector/PDMR Shareholding
31st Jul 20197:00 amRNSInterim Results
23rd Jul 20197:00 amRNSAppointment of Joint Corporate Broker
2nd Jul 201910:35 amRNSPost Stabilisation Notice
21st Jun 20197:00 amRNSDirectorate Change
11th Jun 201912:00 pmRNSHolding(s) in Company
31st May 20195:00 pmRNSHolding(s) in Company
30th May 20195:00 pmRNSDirector Declaration
17th May 20194:04 pmRNSDirector/PDMR Shareholding
15th May 20199:30 amRNSPre Stabilisation Notice
8th May 20192:30 pmRNSResult of AGM
29th Apr 201911:40 amRNSDirector/PDMR Shareholding
18th Apr 20197:00 amRNSQ1 Trading Update
12th Apr 20196:25 pmRNSDirector/PDMR Shareholding - Replacement
11th Apr 20194:37 pmRNSDirector/PDMR Shareholding
10th Apr 20191:57 pmRNSDirector Declaration
1st Apr 20197:00 amRNSBlock listing Interim Review
29th Mar 20197:00 amRNSTotal Voting Rights
27th Mar 201911:18 amRNSAnnual Financial Report
25th Mar 20199:58 amRNSDirector/PDMR Shareholding
12th Mar 201912:17 pmRNSDirector/PDMR Shareholding
6th Mar 20192:00 pmRNSAdditional Listing
6th Mar 20191:05 pmRNSDirector/PDMR Shareholding
1st Mar 20197:00 amRNSInnovative good causes initiative
28th Feb 20195:15 pmRNSDirector/PDMR Shareholding
28th Feb 20197:05 amRNSDirectorate Changes and Appointment of Chairman
28th Feb 20197:00 amRNSFinal Results
15th Feb 20195:15 pmRNSHolding(s) in Company
1st Feb 20197:00 amRNSChange to Director's details
4th Dec 20187:00 amRNSDefined benefit pension scheme buy-in with PIC
20th Nov 20185:17 pmRNSHolding(s) in Company
16th Nov 20184:14 pmRNSHolding(s) in Company
24th Oct 20182:36 pmRNSDirector/PDMR Shareholding
18th Oct 20187:00 amRNSQ3 Trading Update
2nd Oct 201812:17 pmRNSBlock listing Interim Review
25th Sep 20187:25 amRNSDirector Declaration
13th Sep 20184:43 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.